Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.

RPEP-124572025Martin, Corby K; Carmichael, Owen T; Carnell, Susan; Considine, Robert V; Kareken, David A; Dydak, Ulrike; Mattes, Richard D; Scott, David; Shcherbinin, Sergey; Nishiyama, Hiroshi; Knights, Alastair; Urva, Shweta; Biernat, Lukasz; Pratt, Edward; Haupt, Axel; Mintun, Mark; Otero Svaldi, Diana; Milicevic, Zvonko; Coskun, Tamer

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.

Nature medicine, 31(9), 3141-3150

View on PubMed ↗Publisher’s paper ↗

Citation

Martin, Corby K; Carmichael, Owen T; Carnell, Susan; Considine, Robert V; Kareken, David A; Dydak, Ulrike; Mattes, Richard D; Scott, David; Shcherbinin, Sergey; Nishiyama, Hiroshi; Knights, Alastair; Urva, Shweta; Biernat, Lukasz; Pratt, Edward; Haupt, Axel; Mintun, Mark; Otero Svaldi, Diana; Milicevic, Zvonko; Coskun, Tamer. (2025). Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.. Nature medicine, 31(9), 3141-3150. https://doi.org/10.1038/s41591-025-03774-9